Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA

Reliable biomarkers are required to evaluate and manage pancreatic ductal adenocarcinoma. Circulating tumor cells and circulating tumor DNA are shed into blood and can be relatively easily obtained from minimally invasive liquid biopsies for serial assays and characterization, thereby providing a un...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jee‐Soo, Park, Sung Sup, Lee, Young Kyung, Norton, Jeffrey A., Jeffrey, Stefanie S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670020/
https://www.ncbi.nlm.nih.gov/pubmed/31243883
http://dx.doi.org/10.1002/1878-0261.12537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6670020/
https://www.ncbi.nlm.nih.gov/pubmed/31243883
http://dx.doi.org/10.1002/1878-0261.12537

Ejemplares similares